Internal Medicine, Pulmonary Disease · Guaynabo, PR
NPI
1972587970
Since 2005
Specialty
Internal Medicine, Pulmonary Disease
Code 207RP1001X
Group practices
0
Medicare group memberships
Hospitals
1
Hospital affiliations
101 Ave San Patricio Ste 1240
Guaynabo, PR, 00968
Phone (787) 545-5125
Medicare paid, 2024
$57K
1,239 services
Medicare patients, 2024
177
Average age 76
Drug cost, 2024
$31.0M
6,972 prescriptions
Company payments, 2025
$134K
From 26 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Alvaro U Aranda- Rodriguez was code 99214 (office e&m - established), 307 times for 134 patients. In total Alvaro U Aranda- Rodriguez billed 1,239 services in 22 codes, and Medicare paid $57K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-06-27.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 307 | 134 | $88.39 | $27K |
| 94375 Pulmonary Function Testing | Office | 265 | 136 | $28.49 | $7,549 |
| 94200 Pulmonary Function Testing | Office | 252 | 134 | $11.24 | $2,832 |
| 94729 Pulmonary Function Testing | Office | 75 | 74 | $40.34 | $3,025 |
| 94727 Pulmonary Function Testing | Office | 75 | 74 | $32.02 | $2,402 |
| 94640 Treatment - Miscellaneous | Office | 54 | 38 | $6.04 | $326 |
| 99233 Hospital E&M - Subsequent | Facility | 35 | 11 | $91.60 | $3,206 |
| 90656 Vaccine Product | Office | 32 | 32 | $18.94 | $606 |
| 99232 Hospital E&M - Subsequent | Facility | 31 | 12 | $60.65 | $1,880 |
| G0008 Administration of influenza virus vaccine | Office | 31 | 31 | $16.84 | $522 |
| 94618 Pulmonary Function Testing | Office | 21 | 18 | $24.82 | $521 |
| 99205 Office E&M - New | Office | 12 | 12 | $164.01 | $1,968 |
| 95811 Sleep Study | Facility | 11 | 11 | $94.19 | $1,036 |
By year: 2022 $83K for 1,504 services; 2023 $72K for 1,454 services; 2024 $57K for 1,239 services.
Medicare prescription drug claims, 2024
In 2024, the drug Alvaro U Aranda- Rodriguez prescribed most often to Medicare patients was Adempas (Riociguat), with 942 prescriptions and refills. In total Alvaro U Aranda- Rodriguez wrote 6,972 Medicare prescriptions that cost $31.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Adempas Riociguat | 942 | 942 | 105 | $12.6M |
| Azelastine Hcl Generic | 836 | 1,029 | 292 | $22K |
| Opsumit Macitentan | 674 | 674 | 78 | $8.5M |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 475 | 486 | 86 | $320K |
| Fluticasone Propionate Generic | 444 | 559 | 133 | $7,897 |
| Budesonide-Formoterol Fumarate Budesonide/Formoterol Fumarate | 319 | 333 | 77 | $67K |
| Spiriva Respimat Tiotropium Bromide | 289 | 291 | 55 | $155K |
| Symbicort Budesonide/Formoterol Fumarate | 257 | 267 | 74 | $63K |
| Breo Ellipta Fluticasone/Vilanterol | 197 | 203 | 40 | $82K |
| Albuterol Sulfate Hfa Albuterol Sulfate | 160 | 163 | 45 | $7,061 |
| Tyvaso Dpi Treprostinil | 159 | 159 | 21 | $3.7M |
| Tadalafil Generic | 154 | 156 | 21 | $20K |
| Methylprednisolone Generic | 113 | 113 | 68 | $3,184 |
| Montelukast Sodium Generic | 95 | 130 | 21 | $981 |
| Ofev Nintedanib Esylate | 85 | 85 | 13 | $1.1M |
Brand drugs: 4,320 claims; generic drugs: - claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Alvaro U Aranda- Rodriguez $134K ($134K in general payments such as food, travel and fees) from 26 companies. The largest payer was Genzyme Corporation with $35K.
| Company | Payments | Amount |
|---|---|---|
| Genzyme Corporation SNY | 24 | $35K |
| Actelion Pharmaceuticals US, Inc. JNJ | 48 | $32K |
| United Therapeutics Corporation UTHR | 35 | $23K |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 15 | $18K |
| Mallinckrodt Hospital Products Inc. | 6 | $11K |
| Merck Sharp & Dohme LLC MRK | 19 | $8,613 |
| Viatris Specialty LLC | 12 | $2,604 |
| Grifols USA, LLC | 4 | $2,219 |
| AstraZeneca Pharmaceuticals LP AZN | 15 | $512 |
| Janssen Pharmaceuticals, Inc JNJ | 9 | $207 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.